Proactive Care Coordination for Cancer Survivors Who Smoke

Completed · Not applicable

Conditions studied: Cancer

In brief

This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will react to proactive tobacco related communications. Investigators will compare the reach and efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm 1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm randomized design at two urban cancer centers, and will explore cancer survivor attitudes and preferences about proactive tobacco treatment.

Key facts

Study ID

NCT02723656

Run by

NYU Langone Health

People needed

581

Starts

2016-03-01

Expected to finish

2018-09-29

Last updated by the study team

2018-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ICD 9 cancer diagnosis seen at each site in the past two years
• Documentation of current smoking in the cancer registry.

You may not qualify if…

• Dementia
• Stage IV or Stage IIIB cancer

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.